Pain, Postoperative Clinical Trial
Official title:
Comparison of Ultrasound-guided Continuous Serratus Anterior Plane Blockade With Continuous Thoracic Paravertebral Blockade for Perioperative Analgesia Following Video-assisted Thoracoscopic Surgery (VATS)
Thoracic surgery, and surgery involving the chest wall in general, is associated with poorly
controlled acute pain, which may result in delayed functional recovery, and may progress to
chronic pain. Multimodal opioid-sparing analgesia regimens are a key component of the
thoracic surgery enhanced recovery pathway, the aim of which is to improve outcomes in
patients undergoing both minimally invasive and open thoracic surgical procedures. Novel
interfascial plane blocks are emerging as feasible alternatives to central neuraxial
analgesia techniques in a variety of clinical settings.
The aim of this study is to show non-inferiority of serratus anterior blockade compared with
surgically placed paravertebral blocks in the management of perioperative acute pain in
patients undergoing VATS procedures.
Post-thoracotomy pain syndrome is an unwanted complication of thoracic surgery. Poorly
controlled pain may precipitate increased morbidity in the immediate and early postoperative
periods due to its adverse effects on respiratory mechanics and mobilisation, which may
result in further morbidity such as postoperative pulmonary complications and thrombosis.
Poor perioperative management of this pain may also result in the development of chronic
pain. Enhanced recovery, particularly functional recovery has become an important goal in the
perioperative management of our patients. A key principle of this pathway is multimodal
opioid-sparing analgesia to facilitate improved recovery and patient outcomes. Regional
anaesthesia forms the cornerstone of this multimodal analgesia regimen.
Traditionally, thoracic epidural and thoracic paravertebral blockade have been the main forms
of regional anaesthesia utilised in thoracic surgical patients undergoing lung resection.
With the increasing use of minimally invasive thoracic surgery and with a cohort of patients
who may not always be suitable for central neuraxial blockade, alternatives are needed. More
recently, there has been an emerging use of interfascial plane blocks in this patient group.
The interest in these techniques is derived from case reports, case series, cadaveric
studies, and small clinical trials, which have demonstrated clinical efficacy in a variety of
elective and emergency thoracic surgical procedures and also in chronic thoracic pain
syndromes.
The deep serratus anterior plane (deep SAP) block is a relatively new interfascial plane
regional anaesthesia technique, which has been postulated to provide analgesia of the entire
hemithorax. The mechanism of its analgesic effects are believed to occur via blockade of the
lateral cutaneous branches of the thoracic intercostal nerves (T2-T12), which produces
analgesia of the anterolateral chest wall. A recent anatomical study by Mayes et al.
demonstrated consistent blockade of the lateral cutaneous branches of the intercostal nerves.
Clinical studies, although small, have shown dermatomal spread in the T2 - T9 distribution of
the anterolateral chest wall. Therefore, this block presents a potential alternative to
central neuraxial blockade.
However, whether SAP blockade can produce non-inferior analgesia compared with either
thoracic epidural or thoracic paravertebral, both in terms of somatic +/- autonomic blockade,
and the reliability of dermatomal spread, has been questioned by some.
The aim of this randomised controlled trial is to demonstrate non-inferiority of
ultrasound-guided continuous deep serratus anterior plane blockade compared with
surgically-placed continuous paravertebral blockade, for perioperative analgesia, in the
patients undergoing minimally-invasive videoscopic thoracic surgery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05480111 -
The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy
|
Phase 4 | |
Completed |
NCT06129305 -
Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
|
||
Completed |
NCT04401826 -
Micro-surgical Treatment of Gummy Smile
|
N/A | |
Recruiting |
NCT04020133 -
the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction.
|
N/A | |
Completed |
NCT03023462 -
Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair
|
N/A | |
Completed |
NCT03652103 -
Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy
|
Phase 4 | |
Completed |
NCT03546738 -
Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery
|
N/A | |
Withdrawn |
NCT03528343 -
Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy
|
Phase 1/Phase 2 | |
Terminated |
NCT03261193 -
ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain
|
Phase 3 | |
Completed |
NCT02525133 -
Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty
|
Phase 3 | |
Completed |
NCT03244540 -
Regional Analgesia After Cesarean Section
|
Phase 4 | |
Enrolling by invitation |
NCT05316168 -
Post Operative Pain Management for ACL Reconstruction
|
Phase 3 | |
Recruiting |
NCT04130464 -
Intraperitoneal Infusion of Analgesic for Postoperative Pain Management
|
Phase 4 | |
Enrolling by invitation |
NCT04574791 -
Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty
|
N/A | |
Completed |
NCT04073069 -
Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults
|
Phase 4 | |
Completed |
NCT04526236 -
Influence of Aging on Perioperative Methadone Dosing
|
Phase 4 | |
Recruiting |
NCT05351229 -
Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery
|
Phase 4 | |
Enrolling by invitation |
NCT05543109 -
Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block
|
N/A | |
Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
Completed |
NCT04919317 -
Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty
|
Phase 2 |